VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 22 filers reported holding VASCULAR BIOGENICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,849 | +28.5% | 52,572 | -15.4% | 0.00% | – |
| Q3 2022 | $10,000 | -41.2% | 62,159 | +481.5% | 0.00% | -100.0% |
| Q2 2022 | $17,000 | -19.0% | 10,690 | -12.1% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | 0.0% | 12,155 | +19.2% | 0.00% | 0.0% |
| Q3 2021 | $21,000 | -65.6% | 10,196 | -61.5% | 0.00% | – |
| Q1 2018 | $61,000 | – | 26,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |